Monoethanolamine

Monoethanolamine

SCHEMBL6872043

NC(=O)NCCO.NCCO

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MPL

The experimentally established mechanism targets of Monoethanolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
TSHR P16473 5/20 0.42
TDP1 Q9NUW8 1/20 0.36
KDM4E B2RXH2 1/20 0.34
HSD17B10 Q99714 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PAOX Q6QHF9 2/20 0.33
MTNR1A P48039 1/20 0.32
MAOA P21397 2/20 0.32
MAOB P27338 2/20 0.32
NFKB1 P19838 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
LMNA P02545 2/20 0.32
CYP1A2 P05177 1/20 0.32
THPO P40225 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1228640 0.92 ALDH1A1 (0.48) ALDH1A1MEN1USP2MAPTKMT2A
SCHEMBL27663 0.92
SCHEMBL28064222 0.89
SCHEMBL8020141 0.89
SCHEMBL32684120 0.89
Oxalic Acid SCHEMBL29215671 0.84 ALDH1A1 (0.42) ALDH1A1MEN1USP2MAPTKMT2A
SCHEMBL1155049 0.80
Monoethanolamine SCHEMBL4168376 0.79 ALDH1A1 (0.42) ALDH1A1MEN1USP2MAPTKMT2A
Glycerin SCHEMBL19206969 0.78 ALDH1A1 (0.48) ALDH1A1MEN1USP2MAPTKMT2A
Bromide SCHEMBL3701110 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1052250-B1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors SEARLE & CO (US) 2004-07-14 EP disclosed